LDHA and neoplasm: Another study demonstrated that the LDHA inhibition could inhibit tumor glycolysis and improve the efficacy of PD-1 blockade in a murine pMMR CRC model, which was consistent with the clinical findings that highlighted the negative correlation of anti-PD-1 therapeutic efficiency with the serum LDH levels in patients [256, 257, 337].